| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.07 |